Dimitrios Miserlis
Overview
Explore the profile of Dimitrios Miserlis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ring A, Ismaeel A, Wechsler M, Fletcher E, Papoutsi E, Miserlis D, et al.
Ther Adv Cardiovasc Dis
. 2022 May;
16:17539447221096940.
PMID: 35583375
Peripheral artery disease (PAD) is a disease of atherosclerosis in the lower extremities. PAD carries a massive burden worldwide, while diagnosis and treatment options are often lacking. One of the...
12.
Ismaeel A, Fletcher E, Miserlis D, Wechsler M, Papoutsi E, Haynatzki G, et al.
Transl Res
. 2022 Mar;
246:66-77.
PMID: 35288364
Previous studies have demonstrated that circulating microRNA (miR)-210 levels are elevated in peripheral artery disease (PAD) patients. MiR-210 is known to be a negative regulator of mitochondrial respiration; however, the...
13.
Ismaeel A, Laudato J, Fletcher E, Papoutsi E, Tice A, Hwa L, et al.
Nutrients
. 2022 Mar;
14(5).
PMID: 35267991
Previous studies have shown that chronic heavy alcohol consumption and consumption of a high-fat (HF) diet can independently contribute to skeletal muscle oxidative stress and mitochondrial dysfunction, yet the concurrent...
14.
Yan Q, Miserlis D, Jayakumar L, Brahmbhatt R, Mitromaras C, Sideman M, et al.
Ann Vasc Surg
. 2022 Jan;
82:52-61.
PMID: 35051585
Objective: Failure of maturation of arteriovenous fistulae (AVF) remains an ongoing concern for dialysis access. One etiology is the presence of side branches that divert flow from the main AVF...
15.
Ismaeel A, Miserlis D, Papoutsi E, Haynatzki G, Bohannon W, Smith R, et al.
Biochim Biophys Acta Mol Basis Dis
. 2021 Oct;
1868(1):166278.
PMID: 34601016
Background: The vascular pathology of peripheral artery disease (PAD) encompasses abnormal microvascular architecture and fibrosis in response to ischemia-reperfusion (I/R) cycles. We aimed to investigate the mechanisms by which pathological...
16.
Ismaeel A, Greathouse K, Newton N, Miserlis D, Papoutsi E, Smith R, et al.
Nutrients
. 2021 Jul;
13(7).
PMID: 34206667
Peripheral artery disease (PAD) affects over 200 million people worldwide, resulting in significant morbidity and mortality, yet treatment options remain limited. Among the manifestations of PAD is a severe functional...
17.
Miserlis D, Tecos M, Garg N, MacTaggart J, Davies M, Pipinos I
J Vasc Surg Cases Innov Tech
. 2020 Nov;
6(4):622-625.
PMID: 33163746
The Impella is a percutaneously placed intra-arterial flow pump positioned across the aortic valve for circulatory support. A limitation of the Impella is that it lacks a central wire channel,...
18.
Yan Q, Jayakumar L, Sideman M, Ferrer L, Mitromaras C, Miserlis D, et al.
J Vasc Surg
. 2020 Oct;
73(5):1731-1740.e2.
PMID: 33031885
Background: The aim of the present study was to assess the effects of the extent of heel ulceration on the outcomes of limb threatening critical ischemia due to isolated infrapopliteal...
19.
Gao Y, Miserlis D, Longo G, Garg N
JRSM Cardiovasc Dis
. 2020 Sep;
9:2048004020940520.
PMID: 32922767
Purpose: To describe a patient with acute renal artery occlusion who underwent successful revascularization procedure after experiencing a protracted ischemic period, which resulted in successful retrieval of renal function. Case...
20.
Ismaeel A, Papoutsi E, Miserlis D, Lavado R, Haynatzki G, Casale G, et al.
Antioxidants (Basel)
. 2020 Jul;
9(7).
PMID: 32640613
Peripheral artery disease (PAD) pathophysiology extends beyond hemodynamics to include other operating mechanisms, including endothelial dysfunction. Oxidative stress may be linked to endothelial dysfunction by reducing nitric oxide (NO) bioavailability....